DTE
63
4
PRU
59
5
L
62
3
UNH
48
3
FITB
58
5
CCL
53
6
ETN
67
3
ILMN
28
-2
KEY
39
13
LUV
58
-5
DE
62
2
HPE
19
3
UAL
51
6
MOS
45
3
STT
56
3
AXP
59
6
TXT
53
4
COP
48
3
EXPE
66
5
GRMN
48
2
DTE
63
4
PRU
59
5
L
62
3
UNH
48
3
FITB
58
5
CCL
53
6
ETN
67
3
ILMN
28
-2
KEY
39
13
LUV
58
-5
DE
62
2
HPE
19
3
UAL
51
6
MOS
45
3
STT
56
3
AXP
59
6
TXT
53
4
COP
48
3
EXPE
66
5
GRMN
48
2
Financhill
Back

Ocular Therapeutix 10K Form

Sell
41

OCUL
Ocular Therapeutix

Last Price:
$7.95
Seasonality Move:
-9.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUL News And Ratings

See the #1 stock for the next 7 days that we like better than OCUL

OCUL Financial Statistics

Sales & Book Value

Annual Sales: $63.7M
Cash Flow: $-39.6M
Price / Cash Flow: 0
Annual Sales: $2.00
Price / Book: 3.89

Profitability

EPS (TTM): -1.26000
Net Income (TTM): $-193.5M
Gross Margin: $58.1M
Return on Equity: -62.66%
Return on Assets: -42.88%

Ocular Therapeutix Earnings Forecast

Key Ocular Therapeutix Financial Ratios

  • The Gross Profit Margin over the past 13 years for OCUL is 91.17%.
  • The Selling, General & Administrative Expenses for OCUL have been equal to 160.45% of Gross Profit Margin.
  • The Research & Development expenses have been 200.30% of Revenue.
  • The Net Earning history of OCUL is -303.67% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Ocular Therapeutix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUL
CUSIP: 67576A
Website: ocutx.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 10.66
Quick Ratio: 10.26

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OCUL Technical Analysis vs Fundamental Analysis

Sell
41
Ocular Therapeutix (OCUL) is a Sell

Is Ocular Therapeutix a Buy or a Sell?